研究文章
Seroprevalence艾滋病毒合并感染单纯疱疹病毒感染的人在印度东部与危险因素分析
表3
Seroprevalence HSV-2 IgM和HSV-2 IgG抗体。
|
|
艾滋病患者组 |
艾滋病毒对照组 |
Non-HIV对照组 |
| 分的数量。 |
HSV-2 IgM |
|
HSV-2免疫球蛋白 |
|
HSV-2 IgM |
|
HSV-2免疫球蛋白 |
|
HSV-2 IgM |
|
HSV-2免疫球蛋白 |
|
| 整体 |
|
18 (34.6%) |
|
32 (61.5%) |
|
1 (2.2%) |
|
26 (57.8%) |
|
1 (2.2%) |
|
8 (17.8%) |
|
| 根据性别 |
| 男性 |
|
40% |
|
63.3% |
|
0 |
|
60.9% |
|
4% |
|
20% |
| 女 |
|
27% |
|
59.1% |
|
4.5% |
|
54.5% |
|
0 |
|
15% |
|
| 根据年龄(岁) |
| 年龄在18岁至25岁之间 |
|
25% |
|
62.5% |
|
0 |
|
75% |
|
11.1% |
|
11.1% |
| 26 - 35周不等 |
|
35.7% |
|
85.7% |
|
5.9% |
|
47.1% |
|
0 |
|
12.5% |
| 36-45 |
|
34.8% |
|
52.2% |
|
0 |
|
60% |
|
0 |
|
23.8% |
| 46-55 |
|
42.9% |
|
42.9% |
|
0 |
|
60% |
|
0 |
|
14.3% |
|
| 根据合作伙伴的数量 |
| 0 |
|
0 |
|
0 |
|
0 |
|
55.5% |
|
0 |
|
0 |
| 1 |
|
35.7% |
|
42.8% |
|
0 |
|
55.5% |
|
0 |
|
12.9% |
| > 1 |
|
33.3% |
|
83.3% |
|
3.7% |
|
59.2% |
|
16.6% |
|
66.7% |
|
| 根据收入群体 |
| l |
|
25% |
|
75% |
|
0 |
|
66.7% |
|
0 |
|
0 |
| UL |
|
43.3% |
|
63.3% |
|
0 |
|
61.1% |
|
0 |
|
26.7% |
| LM |
|
23.5% |
|
58.8% |
|
0 |
|
55.5% |
|
5.5% |
|
16.7% |
| 嗯 |
|
0 |
|
0 |
|
33.3% |
|
0 |
|
0 |
|
14.2% |
| U |
|
0 |
|
0 |
|
0 |
|
100% |
|
0 |
|
0 |
|
| 根据文化地位 |
| 生病了 |
|
28.5% |
|
71.4% |
|
0 |
|
45.4% |
|
0 |
|
25% |
| P |
|
41.3% |
|
55.1% |
|
0 |
|
66.7% |
|
0 |
|
25% |
| 米 |
|
11.1% |
|
66.7% |
|
0 |
|
58.7% |
|
0 |
|
20% |
| 年代 |
|
50% |
|
100% |
|
10% |
|
70% |
|
8.3% |
|
16.6% |
| H |
|
33.3% |
|
33.3% |
|
0 |
|
50% |
|
0 |
|
9.1% |
|
|
L,低;UL、较高的低;LM,降低中间;嗯,中上;U,上层;病了,文盲;P,主;米,中间;年代,二级;H, H以上。
|
